Top of page

Gil Savir

Associate in our Capital Markets practice.

Gil advises U.S., European and Israeli issuers on various fundraising activities, including initial public offerings, other equity offerings, and public and private investment-grade and convertible debt offerings. He also advises clients ranging from early-stage privately held companies to well-known seasoned issuers on governance, SEC reporting, strategic transactions and other corporate law matters. His practice ranges across a verity of industries, including deep-tech, cybersecurity, biotech, fintech and consumer and retail.

Experience highlights

  • Amdocs Limited on its $650 million SEC-registered debt offering
  • Max Stock Ltd. on its international initial offering
  • CureVac N.V. in connection with its Nasdaq IPO
  • Ltd. in connection with its Rule 144A offering
  • Gamida Cell Ltd. in connection with its SEC-registered follow-on offering of ordinary shares
  • Oak Street Health, Inc. in connection with its NYSE IPO
View all experience
S.J.D., University of Michigan Law School
  • Michigan Grotius Fellowship
  • Phi Kappa Phi
  • Scholarly Writing Award
LL.M., Taxation, University of Michigan Law School
  • Phi Kappa Phi
LL.B., College of Management, Haim Striks School of Law
Professional history
  • Davis Polk since 2015
Back to top